Study Evaluating Bapineuzumab In Alzheimer Disease Subjects

Completed · Phase 2 · Has a placebo group

Conditions studied: Alzheimer Disease

In brief

The study will evaluate the safety and effectiveness of bapineuzumab for the treatment of mild to moderate Alzheimer disease. Subjects will be in the study for six months and will receive subcutaneous injections once per week.

Key facts

Study ID

NCT00663026

Run by

Pfizer

People needed

79

Starts

2008-11-01

Expected to finish

2010-10-01

Last updated by the study team

2013-11-15

Who can join

Age: 50 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of probable Alzheimer Disease according to National Institute of Neurological and Communicative Disorders and Stroke/Alzheimer's Disease and Related Disorders Association (NINCDS/ADRDA) criteria
• Mini-Mental State Examination (MMSE) score 16-26

You may not qualify if…

• Magnetic Resonance Imaging (MRI) showing other brain abnormalities
• Other diagnosed neurological or psychiatric disorders

Where it is running

• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Sun City, Arizona, United States
• Pfizer Investigational Site — Encino, California, United States
• Pfizer Investigational Site — Los Alamitos, California, United States
• Pfizer Investigational Site — Newport Beach, California, United States
• Pfizer Investigational Site — Delray Beach, Florida, United States
• Pfizer Investigational Site — Hallandale, Florida, United States
• Pfizer Investigational Site — West Palm Beach, Florida, United States
• Pfizer Investigational Site — Decatur, Georgia, United States
• Pfizer Investigational Site — Lawrenceville, Georgia, United States
• Pfizer Investigational Site — Wichita, Kansas, United States
• Pfizer Investigational Site — Rochester, New York, United States
• Pfizer Investigational Site — East Providence, Rhode Island, United States
• Pfizer Investigational Site — Providence, Rhode Island, United States
• Pfizer Investigational Site — Dallas, Texas, United States
• Pfizer Investigational Site — Bennington, Vermont, United States
• Pfizer Investigational Site — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.